Quarterly Consolidated Statement Of Cash Flows

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7607422

Concept As at
2022-02-28
2021-03-01 to
2022-02-28
As at
2021-02-28
2020-03-01 to
2021-02-28
As at
2020-02-29
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
18,282,000,000 JPY
11,609,000,000 JPY
Interest and dividends received
1,446,000,000 JPY
1,734,000,000 JPY
Interest paid
-20,000,000 JPY
-9,000,000 JPY
Income taxes paid
-505,000,000 JPY
-7,320,000,000 JPY
Net cash provided by (used in) operating activities
19,199,000,000 JPY
5,289,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-3,610,000,000 JPY
-3,341,000,000 JPY
Proceeds from sale of property, plant and equipment
37,000,000 JPY
642,000,000 JPY
Purchase of investment securities
-340,000,000 JPY
-191,000,000 JPY
Proceeds from collection of loans receivable
2,000,000 JPY
2,000,000 JPY
Net cash provided by (used in) investing activities
-13,060,000,000 JPY
7,815,000,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-77,000,000 JPY
-69,000,000 JPY
Purchase of treasury shares
-8,043,000,000 JPY
-2,000,000 JPY
Dividends paid
-6,839,000,000 JPY
-6,806,000,000 JPY
Dividends paid to non-controlling interests
-44,000,000 JPY
-115,000,000 JPY
Other, net
-144,000,000 JPY
-94,000,000 JPY
Net cash provided by (used in) financing activities
-15,189,000,000 JPY
-7,187,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
3,944,000,000 JPY
-1,559,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-5,106,000,000 JPY
4,357,000,000 JPY
Cash and cash equivalents
86,247,000,000 JPY
91,354,000,000 JPY
86,996,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.